COCH Stock Overview
A hearing health company, focuses on providing medical technologies across the hearing loss spectrum. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Envoy Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.29 |
| 52 Week High | US$11.46 |
| 52 Week Low | US$1.08 |
| Beta | 2.36 |
| 11 Month Change | -11.24% |
| 3 Month Change | -23.41% |
| 1 Year Change | -17.03% |
| 33 Year Change | -76.56% |
| 5 Year Change | n/a |
| Change since IPO | -76.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| COCH | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 6.5% | 1.7% | 1.6% |
| 1Y | -17.0% | 22.5% | 32.3% |
Return vs Industry: COCH underperformed the US Medical Equipment industry which returned 22.6% over the past year.
Return vs Market: COCH underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| COCH volatility | |
|---|---|
| COCH Average Weekly Movement | 12.1% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: COCH's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: COCH's weekly volatility has decreased from 34% to 12% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 34 | Brent Lucas | www.envoymedical.com |
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company’s medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants.
Envoy Medical, Inc. Fundamentals Summary
| COCH fundamental statistics | |
|---|---|
| Market cap | US$44.74m |
| Earnings (TTM) | -US$25.17m |
| Revenue (TTM) | US$278.00k |
166.8x
P/S Ratio-1.8x
P/E RatioIs COCH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COCH income statement (TTM) | |
|---|---|
| Revenue | US$278.00k |
| Cost of Revenue | US$819.00k |
| Gross Profit | -US$541.00k |
| Other Expenses | US$24.63m |
| Earnings | -US$25.17m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.24 |
| Gross Margin | -194.60% |
| Net Profit Margin | -9,053.24% |
| Debt/Equity Ratio | -77.5% |
How did COCH perform over the long term?
See historical performance and comparison